This inventor holds 1 USPTO granted patent. Top assignee: Technion Research & Development Foundation Ltd. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Emily Hersh-Avitan: Innovator in Cancer Biomarkers
Introduction
Emily Hersh-Avitan is a prominent inventor based in Tiberias, Israel. She has made significant contributions to the field of cancer research through her innovative work on biomarkers. Her dedication to advancing medical science is evident in her patented inventions.
Latest Patents
Emily holds a patent for a prognostic biomarker in cancer. The invention is directed to a monoclonal antibody or an antigen-binding portion thereof that has specific binding affinity to RING finger protein 4 (RNF4). This invention is crucial for detecting RNF4-associated diseases in subjects, particularly cancer.
Career Highlights
Emily is associated with the Technion Research & Development Foundation Ltd., where she continues to work on groundbreaking research. Her expertise in the field of cancer biomarkers has positioned her as a key figure in medical innovation.
Collaborations
Emily collaborates with notable colleagues, including Amir Oryan and Yaniv Zohar, who contribute to her research endeavors.
Conclusion
Emily Hersh-Avitan's work exemplifies the impact of innovative research in the medical field, particularly in cancer detection and treatment. Her contributions are paving the way for future advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile